Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Observational Study in Patients With Liver Cirrhosis Who Have Hepatic Decompensation (OPAL)

NCT06380335 is registered in ClinicalTrials.gov with Resolution Therapeutics Limited as lead sponsor.

NCT NCT06380335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06380335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Observational Study in Patients With Liver Cirrhosis Who Have Hepatic Decompensation (OPAL)
Lead sponsor
Resolution Therapeutics Limited
Phase
Observational
Overall status
Active, not recruiting
Start date
October 10, 2023
Completion date
April 3, 2030
Enrollment
24 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis